• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Passage Bio Unveils 2025 Financials, Recent Business Highlights

    GLOBENEWSWIRE

    Passage Bio To Participate In Upcoming Investor Conferences

    GLOBENEWSWIRE

    Passage Bio Unveils Q3 2025 Financials & Business Updates

    GLOBENEWSWIRE

    Passage Bio To Present at Guggenheim Healthcare Innovation

    GLOBENEWSWIRE

    Passage Bio Joins Chardan`s Genetic Medicines Conference

    GLOBENEWSWIRE

    Passage Bio Joins H.C. Wainwright Global Investment Conference

    GLOBENEWSWIRE

    Passage Bio Reports Q2 2025 Results and Business Highlights

    GLOBENEWSWIRE

    Passage Bio Reports Q1 2025 Results and Business Highlights

    GLOBENEWSWIRE

    Passage Bio Reports Q4, Full-Year 2024 Financials, Updates

    GLOBENEWSWIRE

    Passage Bio to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Passage Bio Shares Data From Uplift-D FTD-GRN Study

    GLOBENEWSWIRE

    Passage Bio Reports Q3 2024 Financial Results & Business Highlights

    GLOBENEWSWIRE

    Passage Bio to Present at Guggenheim Securities Health Conference

    GLOBENEWSWIRE

    Passage Bio Presents Data For PBFT02 In FTD-GRN At ESGCT

    GLOBENEWSWIRE

    Passage Bio To Present At Chardan Genetic Medicines Conference

    GLOBENEWSWIRE

    Passage Bio To Present FTD-GRN Data At ISFTD2024

    GLOBENEWSWIRE

    Passage Bio Welcomes Tom Kassberg to Board of Directors

    GLOBENEWSWIRE

    Passage Bio To Present At H.C. Wainwright Investment Conference

    GLOBENEWSWIRE

    Passage Bio Reports Q2 2024 Results And Recent Business Highlights

    GLOBENEWSWIRE

    Passage Bio to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Passage Bio Out-Licenses Programs To GEMMA Biotherapeutics

    GLOBENEWSWIRE

    Passage Bio At Chardan Cell Therapy Summit

    GLOBENEWSWIRE

    Passage looks to offload lead program, 2 other assets

    FIERCE BIOTECH

    Passage Bio Announces Promising Initial Data From Phase 1/2 Trial of PBFT02

    GLOBENEWSWIRE

    Passage Bio lays off 26% of staff, leadership shuffle

    ENDPTS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.